Hairy Cell Leukemia with Unusual Loss of CD103 in a Subset of the Neoplastic Population: Immunophenotypic and Cell Cycle Analysis by Flow Cytometry

Por Yuan, Constance M, Yang, Li-Jun
Publicado em 2008

Novel CD19 Expression in a Peripheral T cell lymphoma: a flow cytometry case report with morphologic correlation

Por Rizzo, Kathryn, Stetler-Stevenson, Maryalice, Wilson, Wyndham, Yuan, Constance M.
Publicado em 2009

Flow Cytometry Increases the Sensitivity of Detection of Leukemia and Lymphoma Cells in Bronchoalveolar Lavage Specimens

Por Song, Joo Y., Filie, Armando C., Venzon, David, tevenson, Maryalice Stetler-S, Yuan, Constance M.
Publicado em 2012

Visual Inspection Versus Quantitative Flow Cytometry to Detect Aberrant CD2 Expression in Malignant T Cells

Por Arun, Indu, Wulu, Jacqueline A., Janik, John E., Jasper, Gregory A., Yuan, Constance M., Venzon, David, Stetler-Stevenson, Maryalice
Publicado em 2010

Distinguishing Hairy Cell Leukemia Variant from Hairy Cell Leukemia: Development and Validation of Diagnostic Criteria

Por Shao, Haipeng, Calvo, Katherine R., Grönborg, Marlene, Tembhare, Prashant R., Kreitman, Robert J., Stetler-Stevenson, Maryalice, Yuan, Constance M.
Publicado no Leuk Res (2013)

Characterization of CD22 Expression in Acute Lymphoblastic Leukemia

Por Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Richards, Kelly, Delbrook, Cindy, Kreitman, Robert J., Pastan, Ira, Wayne, Alan S.
Publicado no Pediatr Blood Cancer (2015)

Quantification of Expression of Antigens Targeted by Antibody Based Therapy in Chronic Lymphocytic Leukemia

Por Tembhare, Prashant R., Marti, Gerald, Wiestner, Adrian, Degheidy, Heba, Farooqui, Mohammed, Kreitman, Robert J., Jasper, Gregory A, Yuan, Constance M., Liewehr, David, Venzon, David, Stetler-Stevenson, Maryalice
Publicado no Am J Clin Pathol (2013)

Expression of the IL-6 Receptor Alpha Chain (CD126) in Normal and Abnormal Plasma Cells in Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma

Por Abdel-Raouf Salem, Dalia, Korde, Neha, Venzon, David J., Liewehr, David J., Maric, Irina, Calvo, Katherine R., Braylan, Raul, Tembhare, Prashant R., Yuan, Constance M, Landgren, Carl Ola, Stetler-Stevenson, Maryalice
Publicado no Leuk Lymphoma (2017)

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Por Haso, Waleed, Lee, Daniel W., Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pastan, Ira H., Dimitrov, Dimiter S., Morgan, Richard A., FitzGerald, David J., Barrett, David M., Wayne, Alan S., Mackall, Crystal L., Orentas, Rimas J.
Publicado em 2013

Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma

Por Shalabi, Haneen, Kraft, Ira L., Wang, Hao-Wei, Yuan, Constance M., Yates, Bonnie, Delbrook, Cindy, Zimbelman, Julie D., Giller, Roger, Stetler-Stevenson, Maryalice, Jaffe, Elaine S., Lee, Daniel W., Shern, Jack F., Fry, Terry J., Shah, Nirali N.
Publicado no Haematologica (2018)

Flow Cytometric Differentiation of Abnormal and Normal Plasma Cells in the Bone Marrow in Patients with Multiple Myeloma and Its Precursor Diseases

Por Tembhare, Prashant R., Yuan, Constance M., Venzon, David, Braylan, Raul, Korde, Neha, Manasanch, Elisabet, Zuchlinsky, Diamond, Calvo, Katherine, Kurlander, Roger, Bhutani, Manisha, Tageja, Nishant, Maric, Irina, Mulquin, Marcia, Roschewski, Mark, Kwok, Mary, Liewehr, David, Landgren, Ola, Stetler-Stevenson, Maryalice
Publicado em 2013

Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method

Por Manasanch, Elisabet E., Salem, Dalia A., Yuan, Constance M., Tageja, Nishant, Bhutani, Manisha, Kwok, Mary, Kazandjian, Dickran, Carter, George, Steinberg, Seth M., Zuchlinski, Diamond, Mulquin, Marcia, Calvo, Katherine, Maric, Irina, Roschewski, Mark, Korde, Neha, Braylan, Raul, Landgren, Ola, Stetler-Stevenson, Maryalice
Publicado no Leuk Lymphoma (2014)

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Por Ahn, Inhye E., Underbayev, Chingiz, Albitar, Adam, Herman, Sarah E. M., Tian, Xin, Maric, Irina, Arthur, Diane C., Wake, Laura, Pittaluga, Stefania, Yuan, Constance M., Stetler-Stevenson, Maryalice, Soto, Susan, Valdez, Janet, Nierman, Pia, Lotter, Jennifer, Xi, Liqiang, Raffeld, Mark, Farooqui, Mohammed, Albitar, Maher, Wiestner, Adrian
Publicado no Blood (2017)

Direct in vivo Evidence for Increased Proliferation of CLL Cells in Lymph Nodes Compared to Bone Marrow and Peripheral Blood

Por Herndon, Thomas M., Chen, Shih-Shih, Saba, Nakhle S., Valdez, Janet, Emson, Claire, Gatmaitan, Michelle, Tian, Xin, Hughes, Thomas E., Sun, Clare, Arthur, Diane C., Stetler-Stevenson, Maryalice, Yuan, Constance M., Niemann, Carsten U., Marti, Gerald E., Aue, Georg, Soto, Susan, Farooqui, Mohammed Z.H., Herman, Sarah E.M., Chiorazzi, Nicholas, Wiestner, Adrian
Publicado no Leukemia (2017)

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

Por Kochenderfer, James N., Somerville, Robert P.T., Lu, Tangying, Shi, Victoria, Bot, Adrian, Rossi, John, Xue, Allen, Goff, Stephanie L., Yang, James C., Sherry, Richard M., Klebanoff, Christopher A., Kammula, Udai S., Sherman, Marika, Perez, Arianne, Yuan, Constance M., Feldman, Tatyana, Friedberg, Jonathan W., Roschewski, Mark J., Feldman, Steven A., McIntyre, Lori, Toomey, Mary Ann, Rosenberg, Steven A.
Publicado no J Clin Oncol (2017)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

Por Fry, Terry J., Shah, Nirali N., Orentas, Rimas J., Stetler-Stevenson, Maryalice, Yuan, Constance M., Ramakrishna, Sneha, Wolters, Pamela, Martin, Staci, Delbrook, Cindy, Yates, Bonnie, Shalabi, Haneen, Fountaine, Thomas J., Shern, Jack F., Majzner, Robbie G., Stroncek, David F., Sabatino, Marianna, Feng, Yang, Dimitrov, Dimiter S., Zhang, Ling, Nguyen, Sang, Qin, Haiying, Dropulic, Boro, Lee, Daniel W., Mackall, Crystal L.
Publicado no Nat Med (2017)

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Por Ahn, Inhye E., Farooqui, Mohammed Z. H., Tian, Xin, Valdez, Janet, Sun, Clare, Soto, Susan, Lotter, Jennifer, Housel, Stephanie, Stetler-Stevenson, Maryalice, Yuan, Constance M., Maric, Irina, Calvo, Katherine R., Nierman, Pia, Hughes, Thomas E., Saba, Nakhle S., Marti, Gerald E., Pittaluga, Stefania, Herman, Sarah E. M., Niemann, Carsten U., Pedersen, Lone B., Geisler, Christian H., Childs, Richard, Aue, Georg, Wiestner, Adrian
Publicado no Blood (2018)